CA2340983A1 - Optical oxidative enzyme-based sensors - Google Patents
Optical oxidative enzyme-based sensors Download PDFInfo
- Publication number
- CA2340983A1 CA2340983A1 CA002340983A CA2340983A CA2340983A1 CA 2340983 A1 CA2340983 A1 CA 2340983A1 CA 002340983 A CA002340983 A CA 002340983A CA 2340983 A CA2340983 A CA 2340983A CA 2340983 A1 CA2340983 A1 CA 2340983A1
- Authority
- CA
- Canada
- Prior art keywords
- oxygen
- porphyrin
- oxidative enzyme
- phenanthroline
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/525—Multi-layer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)
Abstract
The invention discloses enzyme-based optical sensors for detecting blood components which are substrates for oxidative enzymes, the sensors advantageously employing a multiple-layer structure featuring a thin, rapidly responding, optical, oxygen sensing layer. The sensors comprise, in order, a) an enzymatic layer containing an oxidative enzyme or enzyme cascade in a water and oxygen-permeable matrix; b) an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeable matrix; and which is preferably deposited onto c) a light-transmissive substrate. Embodiments of the invention may further include a rapidly hydrating gas-permeable cover, or spacer, layer deposited over the enzymatic layer. A particulate filler material may be included in an effective amount in the oxygen sensing layer to reduce sample light scattering effects. The sensors of the disclosure may be used to detect creatinine and other enzyme-oxidizable analytes such as glucose, lactate or cholesterol, and may be made easily using standard coating techniques known in the art. These sensors are suitable for multiple analyses, but the materials and methods used allow the sensors to be disposable as well, allowing their wide use in medical and analytical applications.
Description
OPTICAL OXIDATIVE ENZYME-BASED SENSORS
BACKGROUND OF THE INVENTION
This invention generally relates to instrumentation for sensing various blood analytes, and more particularly towards optical sensors for detecting blood components which are substrates for oxidative enzymes.
Various sensors have been described in the art for measuring the presence of a substrate which may be enzymatically oxidized. Permanent or multiple use sensors have been made, for example, as in U. S. Patent No. 5,494,562, disclosing an electrochemical glucose sensor wherein the enzyme glucose oxidase is co-immobilized in a platinizf:d carbon paste in contact with an electrode. The paste is further covered with a sernipermeable porous polymer to permit the movement of hydrated glucose and oxygen gas to the paste, where the active enzyme converts these substrates to peroxide andl gluconate. The polarized electrode then delivers a current and the reoxidation of peroxide to oxygen may be measured amperometrica.lly.
Examples of other amperometric sensor technologies have been described in U.
S.
Patent Nos. 4,680,268, 5,:352,348, and 5,298,144. These sensors are disadvantageous for use in disposable applications, because they were designed to function in a multiuse format with an elaborate instrument system, and they employ expensive materials and methods of manufacture as well as requiring wet up and calibration before use.
Another example of permanent or multiple use sensors, using fiber optic glucose sensors, is disclosed in U. S. Patent No. 4,974,929, describing a chamber filled with an oxygen quenchable dye at the end of a fiber surrounded by a double jacketed wall. Sandwiched between the wall jackets is a crosslinked polymer layer containing the enzyme glucose oxidase. The glucose and oxygen consumption at the cylinder wall lowers oxygen diffusion into the cylinder space. This sensor requires a fair degree of manual assembly and is also not suitable for inexpensive, routine single CONFIRMATION COPY
use measurement applications. Each sensor must also be individually calibrated before use, and employs. a large cylindrical volume for dye equilibration and accordingly suffers in response speed due to the requirement for bulk equilibration effects.
Disposable or "one-shot" sensors. on the other hand. have been disclosed also, such as the colorimetric sensor set forth in U. S. Patent No. 5,208,147.
Disposable dry reagent strips, e.g., L1.S. Patent Nos. 3,992,158, 4,689,309, and 5,520,883, were developed specifically for single use applications. In operation, the sample hydrates the test strip and reagents are consumed in the development of a colorimetric change 10 based on peroxide chemistries. They can be stored dry, are ready to use on demand, and find use in "wet" blood or serum chemistry, where the strips become saturated during use. However, th,e hydration and depletion of reactive chemical reagents in these strips effectively prevents their re-use. Handling and biohazard disposal of the many individually used test elements that would routinely be generated is a drawback.
I 5 In the development of optical sensors which are inexpensive to manufacture and may be used in a rapid point of care setting, optical coatings and membranes containing luminescent dyes on light-transmissive substrates for the detection and measurement of O, in blood, have been developed and are incorporated by reference as United State application number 08/617,714. An advantage of these sensors is that 20 it is possible to bring the sensor into intimate contact with a blood sample while transmitting excitation light through the transparent substrate from the "back" side of the sensor, to enable subsequent detection of the luminescent radiation emitted from the luminescent dye from the same side of the sensor. Such coatings or membranes are quite thin, typically I-SP.m for pH and oxygen sensors, and show an extremely 25 rapid response.
However, the application of such thin optical coating-based technologies to the area of glucose determination is not straightforward. Firstly,measurements of oxygen uptake in blood are directly affected by the oxygen buffering capacity of a blood sample itself. If blood is introduced into a measurement system containing an optical 30 sensor, red blood cells {R.BCs) will be in contact with the sensor. Since the principal of operation of optical glucose sensors is based on oxidization of available glucose in the blood sample by immobilized glucose oxidase in the sensor (i.e.. the detection of oxygen is directly correlatable to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. As such, red blood cells (RBCs) in contact with the sensor will sense the low oxygen concentration at the membrane surface and respond by releasing bound oxygen. thus acting as an oxygen buffer and skewing the results obtained.
Secondly. a large fraction of the excitation light (in some cases as much as 95%) as well as the luminescent energy emitted from the sensing layer from these thin membranes passes into the sample (blood) to be absorbed, scattered, or reflected back 10 into the sensing layer and into the detection optics. These effects can.
together, produce a four-fold change in luminescence signal level between a perfectly absorbing and perfectly reflecting sample, thus presenting a significant source of uncertainty in the use of luminescent optical sensors, particularly if used in the simplest amplitude readout mode.
15 Accordingly, it has been desired to obtain optical sensors for measuring oxidizable analytes which are inexpensive enough to design and manufacture to make them disposable, avoid the aforementioned drawbacks, and also allow multiple uses if desired.
SUMMARY OF THE INVENTION
20 The presently-disclosed invention relates to enzyme-based optical sensors for detecting blood components which are substrates for oxidative enzymes. the sensors advantageously employing a multiple-layer structure featuring a thin, rapidly responding, optical. oxygen sensing layer. In one embodiment. the sensor comprises, in order. a) a rapidly hydrating gas-permeable cover. or spacer, layer; b) an enzymatic 25 layer containing an oxidative enzyme also in a water and oxygen-permeable matrix; c) an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeabie matrix; and, preferably, d) a light-transmissive substrate. In another embodiment the oxygen sensing layer further comprises an effective amount of a particulate filler material to reduce or eliminate sample light scattering effects. The 30 inventive sensors may be used to detect glucose and other enzyme-oxidizable analytes such as lactate or cholesterol.
In yet another embodiment. the sensor additionally comprises. an enzyme "cascade" system instead of a single oxidative enzyme in the enzymatic layer containing a water and oxygen-permeable matrix. These sensors may be employed to detect analytes such as creatinine. which may not be enzymatically oxidized by a 5 single enzyme but require several enzymatic steps to generate an oxidizable analyte derivative.
The sensors of this disclosure may be made easily using standard coating techniques known in the art. The sensors are adaptable for reuse, but available materials and methods .allow the sensors to be disposable as well, permitting their 10 wide use in medical and analytical applications.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will be further understood by reference to the disclosure and the attached drawings, of which:
FIG. 1 is a cross-sectional view of a sensor in accordance with one 1 ~ embodiment of the presently disclosed invention;
FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for a glucose sensor as shown in Example I ;
FIG. 3 is a graph illustrating the response of glucose sensors made as shown 20 in Example 2, demonstrating the stability of such sensors after storage;
FIG. 4 is a graph comparing the response of glucose sensors, made in accordance with an embadiment of the invention featuring a spacer layer as in Example 3, to blood doped with glucose to give levels near the same concentrations as the standard solutions;
25 FIG. 5 is a graph illustrating the response of a lactate sensor made as in Example 4;
FIG. 6 is a graph illustrating the linearity of fluorescence signal response to various levels of lactate for the lactate sensor of Example 4;
FIG. 7 is a graph illustrating the response of a cholesterol sensor made as 30 shown in Example S:
FIG. 8 is a sche;matic representation of a test apparatus for measuring an output signal amplitude; of a luminescent optical sensor as described herein;
FIG. 9 is a graph illustrating the response of a creatinine sensor made as shown in Example 6; and FIG. 10 is a graph illustrating the proportional fluorescence signal response to various levels of creatinine for the creatinine sensors of Example 6.
DETAILED DESCRIPTION OF THE INVENTION
"Polymeric sensing layer'', as used herein, refers to articles such as membranes or thin detection layers made of a composition which exhibits the quenching of 10 luminescent energy by a gas such as oxygen ~O,), and can be used for quantitative and qualitative determination of the gas concentration in the environment being measured. The sensing layer or membrane comprises a polymeric material containing at least one luminescent dye species preferably well-dispersed in the polymeric material.
15 "Luminescence"', as used herein, means light emitted from a molecule by radiative dissipation of energy from an electronically excited state.
"Fluorescence", as used herein, means luminescence resulting from the transition between states of identical multiplicity, typically between the lowest excited singlet state and the singlet ground state of the molecule. "Phosphorescence'", as used herein. means ?0 luminescence resulting from the transition between states of differing multiplicity.
typically between the lowest excited triplet state and the singlet ground state.
"Light-transmissive materials", as used herein, refers to materials preferably transmitting at least about 95% of electromagnetic radiation used to induce electronic excitations in luminescent material which result in emissions, more preferably at least 2~ about 99% as measured by the transmission mode.
FIG. 1 depicts an embodiment of an optical sensor 20 in accordance with the disclosure in simplified cross-sectional view. Sensor 20 comprises (from top to bottom) a rapidly hydrating gas-permeable cover layer 10; an enzymatic layer containing an oxidative enzyme also in a water permeable and oxygen-permeable 30 matrix; an oxygen sensing layer 12 containing luminescent dye in a light-transmissive. oxygen-permeable matrix, and a light-transmissive substrate 13.
Further description of each layer is set forth below.
The light transrr~issive substrate 13 is preferably supplied to provide a surface for deposition of the other layers of the oxidative enzyme sensor. It must be light 5 transmissive to allow the excitation radiation from a source situated on the uncoated side of the substrate to pass to the oxygen sensing layer 12, and the luminescent energy emitted from the' oxygen sensing layer 12 pass back to the detection optics also situated on the uncoated side of the substrate. The substrate should have a relatively iow permeability to gases. especially oxygen. so as not to significantly influence the 10 response of the oxygen sensing layer. An exemplary and nonlimiting list of suitable substrates includes MYiLAR~; polyethyleneterephthalate (PET); SARAN: and glass.
The substrate may be flexible or rigid, according to the particular demands of the desired end use. The light-transmissive substrate is preferably polymeric and has a permeability of at most about 0.05 Barrers. more preferably at most about 0.005 15 Barrers, and most preferably at most about 0.0005 Barrers, as measured by the methods disclosed in J. Membrane Sci. 9. 53 ( 1981 ). Other suitable materials will be apparent to those of ordinary skill in the art and are intended to be within the scope of the present invention..
The oxygen sensing layer 12 contains luminescent dye in a light-transmissive, 20 oxygen-permeable matrix.. Any luminescent dyes capable of excitation.
oxygen-quenchable emission. and which may be readily dispersed within the chosen matrix material, may be used. Dyes which may be used in the present invention include, but are not limited to: metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chrorr~ium (III) ions complexed with 2.2~-bipyridine; 1,10-25 phenanthroline; 4,7-diphenyl-1,10-phenanthroline; 4,7-dimethyl-1,10-phenanthroline; 4,7-disulfonated-diphenyl-1,10-phenanthroline; 5-bromo-1,10-phenanthroline; 5-chloro-1.10-phenanthroline; 2-2' bi-2-thiazoline; 2.2'-bithiazole, and other a-diimine ligands as disclosed in, e.g., U.S. Patent No. 4,752,115 and U.S.
Patent No. 5.030,420; a.nd porphyrin. chlorin or phthalocyanine complexes of VO'~.
30 Cu'', Zn'', Pt'' and Pd'~ such as is disclosed in U.S. Patent Nos.
4,810,655 and 5,043.286 and International application number PCT/EP97/03915. Note that a particular fluorescent dye material may be synthesized for a particular use with a given polymeric material based on the desired Ks,. {i.e.. Stern-Volmer constant) of the polymeric sensing merrtbrane. Specific luminescent dye molecules which may be used include tris-(4,7-diphenyl-1,10-phenanthroline) Ru (II); octaethyl-Pt-potphyrin;
octaethyl-Pt-porphyrin ketone; tetrabenzo-Pt-potphyrin; tetraphenyl-Pt-porphyrin;
meso-tetraphenyl-tetrabenzo-Pt-potphyrin; tetracyclohexenyl-Pt-porphyrin;
octaethyl-Pt-chlorin; and tetraphenyl-Pt-chlorin.
In an embodiment, the light-transmissive, oxygen-permeable matrices may comprise a copolymer made by selecting a first homopolymer comprised of first monorneric units, the first homopolymer having a first oxygen permeability value;
selecting a second homopolymer comprised of second monomeric units, the second homopolymer having a second oxygen permeability value that is higher than the first petmeabiiity value; and copolymerizing the first and second monomeric units to obtain a copolymer having an intermediate oxygen permeability value, i.e., between 15 the first and second penneabilites values, the intermediate permeability providing the desired permeability for the desired oxygen sensing formulation, such as described in copending and commonly assigned U.S. Patent Application Number 09/010,161, Attorney Docket No. CCD-239XX, the entire disclosure of which is incorporated herein by reference.
In another embodiment, the oxygen sensing layer rnay further comprise a particulate filler material. in an amount effective to prevent the influence of changes in the sample absorbance and reflectance characteristics as disclosed in United States application number 09/(109,914 and incorporated herein by reference. The filler material appears to effecaively eliminate light transmission through the sensor.
Inclusion of the scattering filler is particularly advantageous for measurements involving luminescence amplitude or amplitude ratios. Accordingly, particles of, e.g., TiO~, zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof, and in particular. Ti0= or BaSO,_ may be added in a range of 0 to about 95 wt% (based on the total weight of the oxygen sensing layer material), preferably 1 to 50wt%, and more preferably S to 50wt°/,.
The oxygen sensing layer 12 is deposited, preferably"as a continuous layer.
e.g., as a membrane, on light-transmissive substrate 13. Standard coating techniques known in the art. such as described in the Examples herein, may be used.
The enzymatic layer 11 includes an oxygen consuming or oxidase based enzyme in an oxygen-permeable matrix which is rapidly hydrated and, which is deposited on the oxygen-sensing layer 12. (By "rapidly hydrating" is meant that water is absorbed rapidly, to enable ions and small charged or water soluble molecules to diffuse through the membrane at about the diffusion speed of the water.) Rapidly hydrating materials which may be used to embed the enzyme in the enzyme layer include poly (vinyl alcohol) or (PVOH), crosslinked polyvinyl alcohol) or (x-PVOH), hydrophylic polyurethanes, polyacrylamides or gelatin.. The matrix of the enzyme layer 11 should. after hydration, be freely permeable to water and to the substrates of the oxidas~e enzyme e.g. oxygen and glucose for example, but it is not necessary that the matrix be light-transmissive. One advantage of the sensors of this 1 S disclosure is that the enzymatic layer need not also function as a "light shield", i.e., attenuate the effects of sample light scattering as described hereinabove.
Instead, the enzymatic layer can be specifically optimized to pass substrates and products, e.g., glucose lactate creatinine and oxygen, to the immobilized enzymes in the enzymatic layer, and preserve the enzymes in an active state.
20 The optical enzyme-based sensors of this disclosure are useful for measuring the concentration of ana~lytes which are substrates of the immobilized oxidative enzymes. Such enzymes include, without limitation, glucose oxidase, cholesterol oxidase. lactate oxidase and sarcosine oxidase.
The enzymatic layer may also comprise an enzyme mixture, such as an 25 enzyme cascade, which allows for the detection of analytes which cannot directly, practically or possibly be the subject of enzymatic oxidation, such as creatinine.
Creatinine is an end product of nitrogen metabolism. In healthy individuals, creatinine is transported from blood to urine by the kidney glomeruli and then excreted in the urine without reabsorption. As such, creatinine is an important 30 diagnostic index of kidney function and muscle diseases. By providing an enzyme cascade system comprising, e.g., creatinine amidohydrase ("CA"), creatine amidinohydrolase ("Clf"), and sarcosine oxidase ("SO"), creatinine is enzymatically converted to glycine, formaldehyde and hydrogen peroxide as follows:
creatinine + H,O --------------------> creatine CA
5 creatine + H,O --------------------> sarcosine + urea CI
sarcosine + H,O + O,_ --------------------> glycine + HCHO + HzOz .
SO
In the final reaction, th.e depletion of oxygen or (Oz ) is measurable by the oxygen 10 sensing layer. Thus, the amount of creatinine in the sample (being directly proportional to the amount of sarcosine oxidized) may be quantitatively determined.
Another embodiment of the present invention includes a rapidly hydrating cover or spacer layer 10 over the enzymatic layer 11. Cover layer 10 ensures more accurate oxygen readings, i.e., those which are not skewed by oxygen concentration 15 effects caused by red blood cell contact with the sensor. As blood is introduced into a system containing an optical sensor as disclosed herein, red blood cells (RBCs) will be in contact with the sensor, i.e., at cover layer 10. Since the principal of operation of the present application is based on the oxidization, e.g., of available glucose in the blood sample by the immobilized glucose oxidase (i.e., the detection of oxygen is 20 directly correlated to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. Without cover layer 10. red blood cells (RBCs) in contact with the sensor will respond to the low oxygen level at the enzyme layer surface and release their bound oxygen. thus skewing the results obtained.
However, provision of a spacer layer 10 over the enzymatic layer 11 ensures that any oxygen 25 released from the RBCs that are proximate to the spacer layer 10 is forced to follow a longer diffusion path than the dissolved oxygen from the blood plasma brought into the membrane sensor under short term "wet up" and normal measurement conditions.
The RBCs are therefore. through equilibrium concentration effects, effectively delayed or prevented from "dumping" their payload of oxygen into the membrane to 30 counter the loss of oxygen immediately adjacent to the oxygen sensor layer.
Accordingly, as the blood sample passes over sensor 20, the oxygen concentration in the blood sample remains unchanged for a period of time sufficient for measurement to take place. Suitablc~ material for the spacer layer includes polyvinyl alcohol), which may be preferably crossiinl:ed for chemical and physical durability.
Other suitable materials include any of the rapidly hydrating materials which may be used in used in the enzyme layer 11 itself.
In operation of the inventive sensors. FIG. 8 describes a suitable device for measuring the luminescent amplitude response of optical sensors 20 in the present invention. The measurement apparatus 140 is comprised of a flow cell assembly and a source and detector sub-system 100. For the optical source and detector sub-system 100, LED source 152 and lens 154 direct excitation light through filter into one leg 182 of fiber optic splitter 180 (e.g., from American Laubscher Corp., 10 Fatrningdale. NY). 'fhe luminescent light signal returning from the sensor 20 through fiber cable 80 and leg 1.84 is passed through filter 168 and aperture 158 before detection by photodiode 172 (e.g., from Hamamatsu Corporation. Bridgewater, NJ).
The output current of emission detector 172 is amplified with a preamplifier 174, such as a Stanford Research SR570 current preamplifier (Stanford Research Systems, Inc., 1 S Sunnyvale, CA), and converted to a voltage and recorded for use in analysis.
For example, with the luminescent dye meso-tetraphenyl--tetrabenzo-Pt-porphyrin ( m-TPTBP), a super bright orange LED (TLOH180P available from Marktech International (:orp, Latham, NY) was used for source 152. An interference filter with a 580nm center wavelength and 100nm half bandwidth (e.g., from Omega 20 Optical. Brattleboro. V'T) was used for filter 162 and a 710 EFLP long wavelength pass filter for emission above 710nm (Omega Optical, Brattleboro. VT) was used for filter 168. Each individual sensor detection layer 14. employing a different dye, such as octaethyl-Pt-porphyrin (OEP) as the luminescent material 2, will typically require its own preferred LED source I52, excitation filter 162 and emission filter 168.
25 When the sensor detection layer 14 of optical sensor 20 is brought in contact with the sample by means of flow cell assembly 60, the optical emission signal that is generated and subsequently conveyed by fiber optic 80 to the source and detector sub-system 100 will be representative of the luminescent amplitude response. For frequency-based measurements one may employ the apparatus described in U.S.
30 Patent Application No. 08/617.714.
The following illustrative and nonlimiting examples are intended to demonstrate certain aspects of the present invention.
Glucose sensors were made in several steps. In a first step, an oxygen sensing layer was prepared and coated on a light transmissive substrate as follows.
Starting monomers were either recrystallized from bulk or freshly distilled to ensure purity. The comonomer mixture comprised of styrene (58%) and acrylonitrile (42%), and an effective amount. about 0.070g, of the initiator azo-bis-isobutyronitrile (MW=192.3) were dissolved in tetrahydrofuran (THF) to form a homogeneous solution. A form was rriade by separating the faces of two glass plates about 2mm apart and providing a rubber sealing gasket therebetween, providing a space in the gasket to allow material to be added to the form. The form was filled with about 32g of the above solution and heated to 60° C for 42 hours in a dry box flushed with nitrogen. The mixture was polymerized to form a solid, then the material was removed and dissolved iin about 150mI of chloroform, glass filtered, and precipitated by adding the chloroform solution to 4lof methanol. The precipitate was dried in a vacuum at 40°C for three days. 2mg of the dye octaethyl-Pt-porphyrin dye (OEP) and 100mg of the styrene/acrylonitrile copolymer was dissolved in lml of tetrahydrofuran (THF) and a thin membrane was spin cast onto a clear MYLAR~ substrate from 20 seconds at 2000 RPM..
In a second step an enzymatic layer comprising glucose oxidase was made and deposited onto the oxygen sensing layer as follows. 2mg of glucose oxidase was dissolved in 200rng of~ d.eionized water. 1.8g of a methanol solution of a random copolymer made from starting monomers N,N-dimethylacrylamide (15%) and N-tert-butylacrylamide monomers was added to the glucose oxidase solution, to provide a homogenous, pale yellow solution upon vortexing. The enzyme layer was formed by spin casting the pale yellow solution on the oxygen sensing layer for 20 seconds at 2000 RPM. The finished sensors were dried at room temperature under vacuum for three hours before testing.
30 FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for the sensor. The response stabilized after about f.0 minutes of testing, and no enzyme loss corresponding to signal loss was observed after about two hours of testing after wet up had occurred.
Another embodiment of a glucose sensor was made in much the same manner 5 as in Example 1 except that the enzyme layer was prepared by combining 2g of an aqueous solution of 13% "crosslinker PVOH" (poly(vinyl alcohol), including N-methyl-4(-formalstyryll)pyridinium crosslinking agent) (Polyseiences Inc.), 2mg of glucose oxidase, and 1 g deionized water to form the solution from which the enzyme layer was spin cast onto the oxygen sensing layer-coated substrate as above.
The 10 glucose sensors were placed in a UV box for 10 minutes to crosslinic the PVOH, removed, and stored under vacuum overnight at room temperature. The sensors were stored in uncovered, Pcari dishes in a drawer for three and one half months, whereupon sensor response, wet-up, and stability were tested as above.
FIG. 3 illustrates the test results for example 2. Testing was performed with 15 the optical instrument described in FIG. 8. The glucose sensors, despite the storage conditions, showed excellent activity when exposed to varying levels of glucose. The response was found to be comparable to the sensors made in Example l and actually a more rapid rate of oxyl;en uptake per amount of enzyme used was found in comparison to the sensors made with the acrylamide matrix.. Also the wet up period 20 was found to be nearly instantaneous as dry sensors gave similarly fast kinetics on the first aqueous sample addition.
To demonstrate the benefits provided by the spacer layer disclosed herein, the glucose sensors made ass in Example 1 were provided with spacer layers as follows. A
25 layer of crosslinked PV'OH was laid down in stripes from a solution prepared by mixing 250mg of the cn~osslinker PVOII solution with 750mg of a 5% aqueous solution of PVOH (average molecular weight of the polymer chains 124.000 to 186,000). The stripes were allowed to dry on the benchtop for a few hours before UV
curing and vacuum storage. Testing was performed with the optical instrument 30 described in FIG. 8. with a preamplifier 174 sensitivity of 100pA/V. In this case a single shot protocol was used where a glucose containing blood sample was passed over a hydrated sensor. As illustrated in FIG. :I, blood has very little effect on suppressing the initial response of the glucose sensors when measured within the first half minute. Rather, the increasing glucose level gives rise to an increased rate of oxygen consumption evidenced by the rapidly rising luminescence signal level.
A lactate sensor was made in much the same manner as example 2 above.
The enzyme layer solution was prepared by combining 2g of lactate oxidase, i g of crosslinker PVOH solution, 1 g of a 7% aqueous solution of PVOH, and 1 g of deionized water. The sensors were tested as above and the data are presented in FIGS.
10 5 and 6. FIGS. 5 and 6 demonstrate the good response and linearity of these sensors.
EXAMPLE S
Sensors comprising cholesterol oxidase in the enzyme layer were made generally as above to produce a cholesterol sensor. The response curve was measured as above and the data are shown in the graph of FIG. 7.
An optical sensor for measuring creatinine was prepared using the same basic procedures outlined in lExamples 1 and 2 for making enzyme sensors except that 2 mg of the dye meso-tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP) was substituted in place of octaethyl-Pt-porphyrin (OEP) in making the oxygen sensing layer. A
thin 20 oxygen sensing layer was first spin cast as a membrane onto a clear MYLAR~
substrate. An enzymatic layer was prepared by adding l3mg creatinine amidohydrase ("CA"), 20mg creatine amidinohydrolase ("CI"), and 23mg sarcosine oxidase (''SO"), to 1 mg, of 7% aqueous solution of PVOH. This solution was spin coated onto the oxygen-sensing layer residing on a transparent substrate, and which 25 had been previously prepared. A third spacer or cover layer was spin coated onto the enzymatic layer from a 10% methanol solution of polyhydroxyethylmethacrylate, whereupon the sensor vvas cured by drying in a fume hood under ambient conditions.
The sensors were tested by exposing the sensor to increasing levels of creatinine ranging from 2.5 mg/dl, 5.0 mg/dl. 12.5 mg/dl. 25 mg/dl and finally 50 mg/dl and 30 interspersed with 0.05 PvI phosphate buffer samples containing no creatinine.. The excitation wavelength used for the sensors was 612 nm while the luminous intensity at 775 nm was measured on a model LS50-b Spectrofluorimeter (available from Perkin Elmer, Norwlk C'C) and equipped with a flow cell to hold the sensors and samples The actual luminescence response for such a sensor is presented in FIG. 9 and shows that the response is rapid and proportional to increasing levels of S creatinine. The plot in FIG. 10 shows the response of several such creatinine sensors.
Having thus described certain embodiments of the invention, various alterations, modifications and improvements will readily occur to those skilled in the art. Such alterations, modifications and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. For 10 example, it is contemplated that additional or intervening layers which do not detract from the essential inventive concept are intended to be part of the present invention.
Accordingly, the foregoing description is by way of example only and is not intended as limiting. The invention is limited only as defined in the following claims and their equivalents.
BACKGROUND OF THE INVENTION
This invention generally relates to instrumentation for sensing various blood analytes, and more particularly towards optical sensors for detecting blood components which are substrates for oxidative enzymes.
Various sensors have been described in the art for measuring the presence of a substrate which may be enzymatically oxidized. Permanent or multiple use sensors have been made, for example, as in U. S. Patent No. 5,494,562, disclosing an electrochemical glucose sensor wherein the enzyme glucose oxidase is co-immobilized in a platinizf:d carbon paste in contact with an electrode. The paste is further covered with a sernipermeable porous polymer to permit the movement of hydrated glucose and oxygen gas to the paste, where the active enzyme converts these substrates to peroxide andl gluconate. The polarized electrode then delivers a current and the reoxidation of peroxide to oxygen may be measured amperometrica.lly.
Examples of other amperometric sensor technologies have been described in U.
S.
Patent Nos. 4,680,268, 5,:352,348, and 5,298,144. These sensors are disadvantageous for use in disposable applications, because they were designed to function in a multiuse format with an elaborate instrument system, and they employ expensive materials and methods of manufacture as well as requiring wet up and calibration before use.
Another example of permanent or multiple use sensors, using fiber optic glucose sensors, is disclosed in U. S. Patent No. 4,974,929, describing a chamber filled with an oxygen quenchable dye at the end of a fiber surrounded by a double jacketed wall. Sandwiched between the wall jackets is a crosslinked polymer layer containing the enzyme glucose oxidase. The glucose and oxygen consumption at the cylinder wall lowers oxygen diffusion into the cylinder space. This sensor requires a fair degree of manual assembly and is also not suitable for inexpensive, routine single CONFIRMATION COPY
use measurement applications. Each sensor must also be individually calibrated before use, and employs. a large cylindrical volume for dye equilibration and accordingly suffers in response speed due to the requirement for bulk equilibration effects.
Disposable or "one-shot" sensors. on the other hand. have been disclosed also, such as the colorimetric sensor set forth in U. S. Patent No. 5,208,147.
Disposable dry reagent strips, e.g., L1.S. Patent Nos. 3,992,158, 4,689,309, and 5,520,883, were developed specifically for single use applications. In operation, the sample hydrates the test strip and reagents are consumed in the development of a colorimetric change 10 based on peroxide chemistries. They can be stored dry, are ready to use on demand, and find use in "wet" blood or serum chemistry, where the strips become saturated during use. However, th,e hydration and depletion of reactive chemical reagents in these strips effectively prevents their re-use. Handling and biohazard disposal of the many individually used test elements that would routinely be generated is a drawback.
I 5 In the development of optical sensors which are inexpensive to manufacture and may be used in a rapid point of care setting, optical coatings and membranes containing luminescent dyes on light-transmissive substrates for the detection and measurement of O, in blood, have been developed and are incorporated by reference as United State application number 08/617,714. An advantage of these sensors is that 20 it is possible to bring the sensor into intimate contact with a blood sample while transmitting excitation light through the transparent substrate from the "back" side of the sensor, to enable subsequent detection of the luminescent radiation emitted from the luminescent dye from the same side of the sensor. Such coatings or membranes are quite thin, typically I-SP.m for pH and oxygen sensors, and show an extremely 25 rapid response.
However, the application of such thin optical coating-based technologies to the area of glucose determination is not straightforward. Firstly,measurements of oxygen uptake in blood are directly affected by the oxygen buffering capacity of a blood sample itself. If blood is introduced into a measurement system containing an optical 30 sensor, red blood cells {R.BCs) will be in contact with the sensor. Since the principal of operation of optical glucose sensors is based on oxidization of available glucose in the blood sample by immobilized glucose oxidase in the sensor (i.e.. the detection of oxygen is directly correlatable to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. As such, red blood cells (RBCs) in contact with the sensor will sense the low oxygen concentration at the membrane surface and respond by releasing bound oxygen. thus acting as an oxygen buffer and skewing the results obtained.
Secondly. a large fraction of the excitation light (in some cases as much as 95%) as well as the luminescent energy emitted from the sensing layer from these thin membranes passes into the sample (blood) to be absorbed, scattered, or reflected back 10 into the sensing layer and into the detection optics. These effects can.
together, produce a four-fold change in luminescence signal level between a perfectly absorbing and perfectly reflecting sample, thus presenting a significant source of uncertainty in the use of luminescent optical sensors, particularly if used in the simplest amplitude readout mode.
15 Accordingly, it has been desired to obtain optical sensors for measuring oxidizable analytes which are inexpensive enough to design and manufacture to make them disposable, avoid the aforementioned drawbacks, and also allow multiple uses if desired.
SUMMARY OF THE INVENTION
20 The presently-disclosed invention relates to enzyme-based optical sensors for detecting blood components which are substrates for oxidative enzymes. the sensors advantageously employing a multiple-layer structure featuring a thin, rapidly responding, optical. oxygen sensing layer. In one embodiment. the sensor comprises, in order. a) a rapidly hydrating gas-permeable cover. or spacer, layer; b) an enzymatic 25 layer containing an oxidative enzyme also in a water and oxygen-permeable matrix; c) an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeabie matrix; and, preferably, d) a light-transmissive substrate. In another embodiment the oxygen sensing layer further comprises an effective amount of a particulate filler material to reduce or eliminate sample light scattering effects. The 30 inventive sensors may be used to detect glucose and other enzyme-oxidizable analytes such as lactate or cholesterol.
In yet another embodiment. the sensor additionally comprises. an enzyme "cascade" system instead of a single oxidative enzyme in the enzymatic layer containing a water and oxygen-permeable matrix. These sensors may be employed to detect analytes such as creatinine. which may not be enzymatically oxidized by a 5 single enzyme but require several enzymatic steps to generate an oxidizable analyte derivative.
The sensors of this disclosure may be made easily using standard coating techniques known in the art. The sensors are adaptable for reuse, but available materials and methods .allow the sensors to be disposable as well, permitting their 10 wide use in medical and analytical applications.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will be further understood by reference to the disclosure and the attached drawings, of which:
FIG. 1 is a cross-sectional view of a sensor in accordance with one 1 ~ embodiment of the presently disclosed invention;
FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for a glucose sensor as shown in Example I ;
FIG. 3 is a graph illustrating the response of glucose sensors made as shown 20 in Example 2, demonstrating the stability of such sensors after storage;
FIG. 4 is a graph comparing the response of glucose sensors, made in accordance with an embadiment of the invention featuring a spacer layer as in Example 3, to blood doped with glucose to give levels near the same concentrations as the standard solutions;
25 FIG. 5 is a graph illustrating the response of a lactate sensor made as in Example 4;
FIG. 6 is a graph illustrating the linearity of fluorescence signal response to various levels of lactate for the lactate sensor of Example 4;
FIG. 7 is a graph illustrating the response of a cholesterol sensor made as 30 shown in Example S:
FIG. 8 is a sche;matic representation of a test apparatus for measuring an output signal amplitude; of a luminescent optical sensor as described herein;
FIG. 9 is a graph illustrating the response of a creatinine sensor made as shown in Example 6; and FIG. 10 is a graph illustrating the proportional fluorescence signal response to various levels of creatinine for the creatinine sensors of Example 6.
DETAILED DESCRIPTION OF THE INVENTION
"Polymeric sensing layer'', as used herein, refers to articles such as membranes or thin detection layers made of a composition which exhibits the quenching of 10 luminescent energy by a gas such as oxygen ~O,), and can be used for quantitative and qualitative determination of the gas concentration in the environment being measured. The sensing layer or membrane comprises a polymeric material containing at least one luminescent dye species preferably well-dispersed in the polymeric material.
15 "Luminescence"', as used herein, means light emitted from a molecule by radiative dissipation of energy from an electronically excited state.
"Fluorescence", as used herein, means luminescence resulting from the transition between states of identical multiplicity, typically between the lowest excited singlet state and the singlet ground state of the molecule. "Phosphorescence'", as used herein. means ?0 luminescence resulting from the transition between states of differing multiplicity.
typically between the lowest excited triplet state and the singlet ground state.
"Light-transmissive materials", as used herein, refers to materials preferably transmitting at least about 95% of electromagnetic radiation used to induce electronic excitations in luminescent material which result in emissions, more preferably at least 2~ about 99% as measured by the transmission mode.
FIG. 1 depicts an embodiment of an optical sensor 20 in accordance with the disclosure in simplified cross-sectional view. Sensor 20 comprises (from top to bottom) a rapidly hydrating gas-permeable cover layer 10; an enzymatic layer containing an oxidative enzyme also in a water permeable and oxygen-permeable 30 matrix; an oxygen sensing layer 12 containing luminescent dye in a light-transmissive. oxygen-permeable matrix, and a light-transmissive substrate 13.
Further description of each layer is set forth below.
The light transrr~issive substrate 13 is preferably supplied to provide a surface for deposition of the other layers of the oxidative enzyme sensor. It must be light 5 transmissive to allow the excitation radiation from a source situated on the uncoated side of the substrate to pass to the oxygen sensing layer 12, and the luminescent energy emitted from the' oxygen sensing layer 12 pass back to the detection optics also situated on the uncoated side of the substrate. The substrate should have a relatively iow permeability to gases. especially oxygen. so as not to significantly influence the 10 response of the oxygen sensing layer. An exemplary and nonlimiting list of suitable substrates includes MYiLAR~; polyethyleneterephthalate (PET); SARAN: and glass.
The substrate may be flexible or rigid, according to the particular demands of the desired end use. The light-transmissive substrate is preferably polymeric and has a permeability of at most about 0.05 Barrers. more preferably at most about 0.005 15 Barrers, and most preferably at most about 0.0005 Barrers, as measured by the methods disclosed in J. Membrane Sci. 9. 53 ( 1981 ). Other suitable materials will be apparent to those of ordinary skill in the art and are intended to be within the scope of the present invention..
The oxygen sensing layer 12 contains luminescent dye in a light-transmissive, 20 oxygen-permeable matrix.. Any luminescent dyes capable of excitation.
oxygen-quenchable emission. and which may be readily dispersed within the chosen matrix material, may be used. Dyes which may be used in the present invention include, but are not limited to: metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chrorr~ium (III) ions complexed with 2.2~-bipyridine; 1,10-25 phenanthroline; 4,7-diphenyl-1,10-phenanthroline; 4,7-dimethyl-1,10-phenanthroline; 4,7-disulfonated-diphenyl-1,10-phenanthroline; 5-bromo-1,10-phenanthroline; 5-chloro-1.10-phenanthroline; 2-2' bi-2-thiazoline; 2.2'-bithiazole, and other a-diimine ligands as disclosed in, e.g., U.S. Patent No. 4,752,115 and U.S.
Patent No. 5.030,420; a.nd porphyrin. chlorin or phthalocyanine complexes of VO'~.
30 Cu'', Zn'', Pt'' and Pd'~ such as is disclosed in U.S. Patent Nos.
4,810,655 and 5,043.286 and International application number PCT/EP97/03915. Note that a particular fluorescent dye material may be synthesized for a particular use with a given polymeric material based on the desired Ks,. {i.e.. Stern-Volmer constant) of the polymeric sensing merrtbrane. Specific luminescent dye molecules which may be used include tris-(4,7-diphenyl-1,10-phenanthroline) Ru (II); octaethyl-Pt-potphyrin;
octaethyl-Pt-porphyrin ketone; tetrabenzo-Pt-potphyrin; tetraphenyl-Pt-porphyrin;
meso-tetraphenyl-tetrabenzo-Pt-potphyrin; tetracyclohexenyl-Pt-porphyrin;
octaethyl-Pt-chlorin; and tetraphenyl-Pt-chlorin.
In an embodiment, the light-transmissive, oxygen-permeable matrices may comprise a copolymer made by selecting a first homopolymer comprised of first monorneric units, the first homopolymer having a first oxygen permeability value;
selecting a second homopolymer comprised of second monomeric units, the second homopolymer having a second oxygen permeability value that is higher than the first petmeabiiity value; and copolymerizing the first and second monomeric units to obtain a copolymer having an intermediate oxygen permeability value, i.e., between 15 the first and second penneabilites values, the intermediate permeability providing the desired permeability for the desired oxygen sensing formulation, such as described in copending and commonly assigned U.S. Patent Application Number 09/010,161, Attorney Docket No. CCD-239XX, the entire disclosure of which is incorporated herein by reference.
In another embodiment, the oxygen sensing layer rnay further comprise a particulate filler material. in an amount effective to prevent the influence of changes in the sample absorbance and reflectance characteristics as disclosed in United States application number 09/(109,914 and incorporated herein by reference. The filler material appears to effecaively eliminate light transmission through the sensor.
Inclusion of the scattering filler is particularly advantageous for measurements involving luminescence amplitude or amplitude ratios. Accordingly, particles of, e.g., TiO~, zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof, and in particular. Ti0= or BaSO,_ may be added in a range of 0 to about 95 wt% (based on the total weight of the oxygen sensing layer material), preferably 1 to 50wt%, and more preferably S to 50wt°/,.
The oxygen sensing layer 12 is deposited, preferably"as a continuous layer.
e.g., as a membrane, on light-transmissive substrate 13. Standard coating techniques known in the art. such as described in the Examples herein, may be used.
The enzymatic layer 11 includes an oxygen consuming or oxidase based enzyme in an oxygen-permeable matrix which is rapidly hydrated and, which is deposited on the oxygen-sensing layer 12. (By "rapidly hydrating" is meant that water is absorbed rapidly, to enable ions and small charged or water soluble molecules to diffuse through the membrane at about the diffusion speed of the water.) Rapidly hydrating materials which may be used to embed the enzyme in the enzyme layer include poly (vinyl alcohol) or (PVOH), crosslinked polyvinyl alcohol) or (x-PVOH), hydrophylic polyurethanes, polyacrylamides or gelatin.. The matrix of the enzyme layer 11 should. after hydration, be freely permeable to water and to the substrates of the oxidas~e enzyme e.g. oxygen and glucose for example, but it is not necessary that the matrix be light-transmissive. One advantage of the sensors of this 1 S disclosure is that the enzymatic layer need not also function as a "light shield", i.e., attenuate the effects of sample light scattering as described hereinabove.
Instead, the enzymatic layer can be specifically optimized to pass substrates and products, e.g., glucose lactate creatinine and oxygen, to the immobilized enzymes in the enzymatic layer, and preserve the enzymes in an active state.
20 The optical enzyme-based sensors of this disclosure are useful for measuring the concentration of ana~lytes which are substrates of the immobilized oxidative enzymes. Such enzymes include, without limitation, glucose oxidase, cholesterol oxidase. lactate oxidase and sarcosine oxidase.
The enzymatic layer may also comprise an enzyme mixture, such as an 25 enzyme cascade, which allows for the detection of analytes which cannot directly, practically or possibly be the subject of enzymatic oxidation, such as creatinine.
Creatinine is an end product of nitrogen metabolism. In healthy individuals, creatinine is transported from blood to urine by the kidney glomeruli and then excreted in the urine without reabsorption. As such, creatinine is an important 30 diagnostic index of kidney function and muscle diseases. By providing an enzyme cascade system comprising, e.g., creatinine amidohydrase ("CA"), creatine amidinohydrolase ("Clf"), and sarcosine oxidase ("SO"), creatinine is enzymatically converted to glycine, formaldehyde and hydrogen peroxide as follows:
creatinine + H,O --------------------> creatine CA
5 creatine + H,O --------------------> sarcosine + urea CI
sarcosine + H,O + O,_ --------------------> glycine + HCHO + HzOz .
SO
In the final reaction, th.e depletion of oxygen or (Oz ) is measurable by the oxygen 10 sensing layer. Thus, the amount of creatinine in the sample (being directly proportional to the amount of sarcosine oxidized) may be quantitatively determined.
Another embodiment of the present invention includes a rapidly hydrating cover or spacer layer 10 over the enzymatic layer 11. Cover layer 10 ensures more accurate oxygen readings, i.e., those which are not skewed by oxygen concentration 15 effects caused by red blood cell contact with the sensor. As blood is introduced into a system containing an optical sensor as disclosed herein, red blood cells (RBCs) will be in contact with the sensor, i.e., at cover layer 10. Since the principal of operation of the present application is based on the oxidization, e.g., of available glucose in the blood sample by the immobilized glucose oxidase (i.e., the detection of oxygen is 20 directly correlated to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. Without cover layer 10. red blood cells (RBCs) in contact with the sensor will respond to the low oxygen level at the enzyme layer surface and release their bound oxygen. thus skewing the results obtained.
However, provision of a spacer layer 10 over the enzymatic layer 11 ensures that any oxygen 25 released from the RBCs that are proximate to the spacer layer 10 is forced to follow a longer diffusion path than the dissolved oxygen from the blood plasma brought into the membrane sensor under short term "wet up" and normal measurement conditions.
The RBCs are therefore. through equilibrium concentration effects, effectively delayed or prevented from "dumping" their payload of oxygen into the membrane to 30 counter the loss of oxygen immediately adjacent to the oxygen sensor layer.
Accordingly, as the blood sample passes over sensor 20, the oxygen concentration in the blood sample remains unchanged for a period of time sufficient for measurement to take place. Suitablc~ material for the spacer layer includes polyvinyl alcohol), which may be preferably crossiinl:ed for chemical and physical durability.
Other suitable materials include any of the rapidly hydrating materials which may be used in used in the enzyme layer 11 itself.
In operation of the inventive sensors. FIG. 8 describes a suitable device for measuring the luminescent amplitude response of optical sensors 20 in the present invention. The measurement apparatus 140 is comprised of a flow cell assembly and a source and detector sub-system 100. For the optical source and detector sub-system 100, LED source 152 and lens 154 direct excitation light through filter into one leg 182 of fiber optic splitter 180 (e.g., from American Laubscher Corp., 10 Fatrningdale. NY). 'fhe luminescent light signal returning from the sensor 20 through fiber cable 80 and leg 1.84 is passed through filter 168 and aperture 158 before detection by photodiode 172 (e.g., from Hamamatsu Corporation. Bridgewater, NJ).
The output current of emission detector 172 is amplified with a preamplifier 174, such as a Stanford Research SR570 current preamplifier (Stanford Research Systems, Inc., 1 S Sunnyvale, CA), and converted to a voltage and recorded for use in analysis.
For example, with the luminescent dye meso-tetraphenyl--tetrabenzo-Pt-porphyrin ( m-TPTBP), a super bright orange LED (TLOH180P available from Marktech International (:orp, Latham, NY) was used for source 152. An interference filter with a 580nm center wavelength and 100nm half bandwidth (e.g., from Omega 20 Optical. Brattleboro. V'T) was used for filter 162 and a 710 EFLP long wavelength pass filter for emission above 710nm (Omega Optical, Brattleboro. VT) was used for filter 168. Each individual sensor detection layer 14. employing a different dye, such as octaethyl-Pt-porphyrin (OEP) as the luminescent material 2, will typically require its own preferred LED source I52, excitation filter 162 and emission filter 168.
25 When the sensor detection layer 14 of optical sensor 20 is brought in contact with the sample by means of flow cell assembly 60, the optical emission signal that is generated and subsequently conveyed by fiber optic 80 to the source and detector sub-system 100 will be representative of the luminescent amplitude response. For frequency-based measurements one may employ the apparatus described in U.S.
30 Patent Application No. 08/617.714.
The following illustrative and nonlimiting examples are intended to demonstrate certain aspects of the present invention.
Glucose sensors were made in several steps. In a first step, an oxygen sensing layer was prepared and coated on a light transmissive substrate as follows.
Starting monomers were either recrystallized from bulk or freshly distilled to ensure purity. The comonomer mixture comprised of styrene (58%) and acrylonitrile (42%), and an effective amount. about 0.070g, of the initiator azo-bis-isobutyronitrile (MW=192.3) were dissolved in tetrahydrofuran (THF) to form a homogeneous solution. A form was rriade by separating the faces of two glass plates about 2mm apart and providing a rubber sealing gasket therebetween, providing a space in the gasket to allow material to be added to the form. The form was filled with about 32g of the above solution and heated to 60° C for 42 hours in a dry box flushed with nitrogen. The mixture was polymerized to form a solid, then the material was removed and dissolved iin about 150mI of chloroform, glass filtered, and precipitated by adding the chloroform solution to 4lof methanol. The precipitate was dried in a vacuum at 40°C for three days. 2mg of the dye octaethyl-Pt-porphyrin dye (OEP) and 100mg of the styrene/acrylonitrile copolymer was dissolved in lml of tetrahydrofuran (THF) and a thin membrane was spin cast onto a clear MYLAR~ substrate from 20 seconds at 2000 RPM..
In a second step an enzymatic layer comprising glucose oxidase was made and deposited onto the oxygen sensing layer as follows. 2mg of glucose oxidase was dissolved in 200rng of~ d.eionized water. 1.8g of a methanol solution of a random copolymer made from starting monomers N,N-dimethylacrylamide (15%) and N-tert-butylacrylamide monomers was added to the glucose oxidase solution, to provide a homogenous, pale yellow solution upon vortexing. The enzyme layer was formed by spin casting the pale yellow solution on the oxygen sensing layer for 20 seconds at 2000 RPM. The finished sensors were dried at room temperature under vacuum for three hours before testing.
30 FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for the sensor. The response stabilized after about f.0 minutes of testing, and no enzyme loss corresponding to signal loss was observed after about two hours of testing after wet up had occurred.
Another embodiment of a glucose sensor was made in much the same manner 5 as in Example 1 except that the enzyme layer was prepared by combining 2g of an aqueous solution of 13% "crosslinker PVOH" (poly(vinyl alcohol), including N-methyl-4(-formalstyryll)pyridinium crosslinking agent) (Polyseiences Inc.), 2mg of glucose oxidase, and 1 g deionized water to form the solution from which the enzyme layer was spin cast onto the oxygen sensing layer-coated substrate as above.
The 10 glucose sensors were placed in a UV box for 10 minutes to crosslinic the PVOH, removed, and stored under vacuum overnight at room temperature. The sensors were stored in uncovered, Pcari dishes in a drawer for three and one half months, whereupon sensor response, wet-up, and stability were tested as above.
FIG. 3 illustrates the test results for example 2. Testing was performed with 15 the optical instrument described in FIG. 8. The glucose sensors, despite the storage conditions, showed excellent activity when exposed to varying levels of glucose. The response was found to be comparable to the sensors made in Example l and actually a more rapid rate of oxyl;en uptake per amount of enzyme used was found in comparison to the sensors made with the acrylamide matrix.. Also the wet up period 20 was found to be nearly instantaneous as dry sensors gave similarly fast kinetics on the first aqueous sample addition.
To demonstrate the benefits provided by the spacer layer disclosed herein, the glucose sensors made ass in Example 1 were provided with spacer layers as follows. A
25 layer of crosslinked PV'OH was laid down in stripes from a solution prepared by mixing 250mg of the cn~osslinker PVOII solution with 750mg of a 5% aqueous solution of PVOH (average molecular weight of the polymer chains 124.000 to 186,000). The stripes were allowed to dry on the benchtop for a few hours before UV
curing and vacuum storage. Testing was performed with the optical instrument 30 described in FIG. 8. with a preamplifier 174 sensitivity of 100pA/V. In this case a single shot protocol was used where a glucose containing blood sample was passed over a hydrated sensor. As illustrated in FIG. :I, blood has very little effect on suppressing the initial response of the glucose sensors when measured within the first half minute. Rather, the increasing glucose level gives rise to an increased rate of oxygen consumption evidenced by the rapidly rising luminescence signal level.
A lactate sensor was made in much the same manner as example 2 above.
The enzyme layer solution was prepared by combining 2g of lactate oxidase, i g of crosslinker PVOH solution, 1 g of a 7% aqueous solution of PVOH, and 1 g of deionized water. The sensors were tested as above and the data are presented in FIGS.
10 5 and 6. FIGS. 5 and 6 demonstrate the good response and linearity of these sensors.
EXAMPLE S
Sensors comprising cholesterol oxidase in the enzyme layer were made generally as above to produce a cholesterol sensor. The response curve was measured as above and the data are shown in the graph of FIG. 7.
An optical sensor for measuring creatinine was prepared using the same basic procedures outlined in lExamples 1 and 2 for making enzyme sensors except that 2 mg of the dye meso-tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP) was substituted in place of octaethyl-Pt-porphyrin (OEP) in making the oxygen sensing layer. A
thin 20 oxygen sensing layer was first spin cast as a membrane onto a clear MYLAR~
substrate. An enzymatic layer was prepared by adding l3mg creatinine amidohydrase ("CA"), 20mg creatine amidinohydrolase ("CI"), and 23mg sarcosine oxidase (''SO"), to 1 mg, of 7% aqueous solution of PVOH. This solution was spin coated onto the oxygen-sensing layer residing on a transparent substrate, and which 25 had been previously prepared. A third spacer or cover layer was spin coated onto the enzymatic layer from a 10% methanol solution of polyhydroxyethylmethacrylate, whereupon the sensor vvas cured by drying in a fume hood under ambient conditions.
The sensors were tested by exposing the sensor to increasing levels of creatinine ranging from 2.5 mg/dl, 5.0 mg/dl. 12.5 mg/dl. 25 mg/dl and finally 50 mg/dl and 30 interspersed with 0.05 PvI phosphate buffer samples containing no creatinine.. The excitation wavelength used for the sensors was 612 nm while the luminous intensity at 775 nm was measured on a model LS50-b Spectrofluorimeter (available from Perkin Elmer, Norwlk C'C) and equipped with a flow cell to hold the sensors and samples The actual luminescence response for such a sensor is presented in FIG. 9 and shows that the response is rapid and proportional to increasing levels of S creatinine. The plot in FIG. 10 shows the response of several such creatinine sensors.
Having thus described certain embodiments of the invention, various alterations, modifications and improvements will readily occur to those skilled in the art. Such alterations, modifications and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. For 10 example, it is contemplated that additional or intervening layers which do not detract from the essential inventive concept are intended to be part of the present invention.
Accordingly, the foregoing description is by way of example only and is not intended as limiting. The invention is limited only as defined in the following claims and their equivalents.
Claims (18)
1. An oxidative enzyme sensor having an optical sensing membrane comprising, in order:
a) an enzymatic layer containing an oxidative enzyme in a hydrateable and oxygen permeable matrix.; and b) an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeable matrix wherein said enzymatic layer is disposed on said oxygen sensing layer.
a) an enzymatic layer containing an oxidative enzyme in a hydrateable and oxygen permeable matrix.; and b) an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeable matrix wherein said enzymatic layer is disposed on said oxygen sensing layer.
2. The oxidative enzyme sensor of claim 1 further comprising a light-transmissive substrate wherein said oxygen sensing layer is disposed on said light transmissive substrate.
3. The oxidative enzyme sensor of claim 1 further comprising a rapidly hydrating gas-permeable cover layer disposed over the enzymatic layer.
4. The oxidative enzyme sensor of claim 1 wherein said oxygen sensing layer further comprises a particulate filler material in an effective amount to reduce sample light scattering effects.
5. The oxidative enzyme sensor of claim 2 further comprising a light source and a light detector disposed adjacent said light-transmissive substrate.
6. The oxidative enzyme sensor of claim 1 wherein said enzymatic layer contains an oxidative enzyme specific for substrates selected from the group consisting of glucose, lactate, malate, and cholesterol.
7. The oxidative enzyme sensor of claim 1, wherein said luminescent dye is selected from then group consisting of: ruthenium complexes; porphyrin derivatives; lanthanide complexes; tetrabenzo-Pt-porphyrin; tetraphenyl-Pt-porphyrin; octaethyl-Pt-porphyrin ketone: octaethyl-Pt-porphyrin; octaethyl-Pt-chlorin; tetraphenyl-Pt-chlorin; (4,7-diphenyl-1,1-phenanthroline)3 Ru(II);
ligand metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions with 2.2-bipyridine. 1,10-phenanthroline, 4,7-diphenyl-(1,20-phenanthroline), 4,7-dimethyl-1.10-phenanthroline, 4,7-disulfonated-diphenyl-1,10-phenanthroline. 5-bromo-1.10-phenanthroline. 5-chloro-1,10-phenanthroline. 2-2' bi-2-thiazoline, and 2,2'-bithiazole; meso-tetraphenyl-tetrabenzo-Pt-porphyrin; meso-tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP); and tetracyclohexenyl-meso-tetraphenyl-Pt-porphyrin (TCHPP).
ligand metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions with 2.2-bipyridine. 1,10-phenanthroline, 4,7-diphenyl-(1,20-phenanthroline), 4,7-dimethyl-1.10-phenanthroline, 4,7-disulfonated-diphenyl-1,10-phenanthroline. 5-bromo-1.10-phenanthroline. 5-chloro-1,10-phenanthroline. 2-2' bi-2-thiazoline, and 2,2'-bithiazole; meso-tetraphenyl-tetrabenzo-Pt-porphyrin; meso-tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP); and tetracyclohexenyl-meso-tetraphenyl-Pt-porphyrin (TCHPP).
8. The oxidative enzyme sensor of claim 4 wherein said particulate filler material is selected from the group consisting of TiO2, zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof.
9. The oxidative enzyme sensor of claim 1 wherein said enzymatic layer contains an oxidative enzyme cascade.
10. The oxidative enzyme sensor of claim 9 wherein said oxidative enzyme cascade is specific for creatinine.
11. A method of making an oxidative enzyme sensor having an optical sensing membrane comprising, in order:
a) preparing an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeable matrix; and b) depositing an enzymatic layer on said oxygen sensing layer, said enzymatic layer containing an oxidative enzyme or oxidative enzyme cascade in an oxygen-permeable matrix.
a) preparing an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeable matrix; and b) depositing an enzymatic layer on said oxygen sensing layer, said enzymatic layer containing an oxidative enzyme or oxidative enzyme cascade in an oxygen-permeable matrix.
12. The method of claim 11 further comprising the step of disposing said oxygen sensing layer on a light-transmissive substrate.
13. The method of claim 11 further comprising the step of depositing a rapidly hydrating gas-permeable cover layer on said enzymatic layer.
14. The method of claim 11 wherein said step of preparing further comprises introducing a particulate filler material in an effective amount to reduce sample light scattering effects.
15. The method of claim 11 wherein said step of depositing further comprises depositing said enzymatic layer containing an oxidative enzyme specific for substrates selected from the group consisting of glucose. lactate. and cholesterol.
16. The method of claim 11. wherein said luminescent dye is selected from the group consisting of: ruthenium complexes; porphyrin derivatives; lanthanide complexes; tetrabenzo-Pt-porphyrin; tetraphenyl-Pt-porphyrin; octaethyl-Pt-porphyrin ketone; octaethyl-Pt-porphyrin; octaethyl-Pt-chlorin; tetraphenyl-Pt-chlorin; (4,7-diphenyl-1,1-phenanthroline)3 Ru(II); ligand metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions with 2,2'-bipyridine, 1,10-phenanthroline, 4,7-diphenyl-(1,20-phenanthroline), 4,7-dimethyl-1,10-phenanthroline, 4,7-disulfonated-diphenyl-1,10-phenanthroline. 5-bromo-1,10-phenanthroline, 5-chloro-1,10-phenanthroline, 2-2' bi-2-thiazoline, and 2.2'-bithiazole; meso-tetraphenyl-tetrabenzo-Pt-porphyrin; meso-tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP); and tetracyclohexenyl-meso-tetraphenyl-Pt-porphyrin (TCHPP).
17. The method of claim 14 wherein said step of introducing comprises selecting said particulate filler material from the group consisting of TiO2, zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof.
18. The method of claim 11 wherein said step of depositing further comprises depositing said .enzymatic layer containing an oxidative enzyme cascade specific for creatinine.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/137,616 US6107083A (en) | 1998-08-21 | 1998-08-21 | Optical oxidative enzyme-based sensors |
| US09/137,616 | 1998-08-21 | ||
| PCT/IB1999/001451 WO2000011205A1 (en) | 1998-08-21 | 1999-08-19 | Optical oxidative enzyme-based sensors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2340983A1 true CA2340983A1 (en) | 2000-03-02 |
Family
ID=22478266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002340983A Abandoned CA2340983A1 (en) | 1998-08-21 | 1999-08-19 | Optical oxidative enzyme-based sensors |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6107083A (en) |
| EP (1) | EP1112374A1 (en) |
| JP (1) | JP2002523733A (en) |
| AU (1) | AU5188399A (en) |
| CA (1) | CA2340983A1 (en) |
| WO (1) | WO2000011205A1 (en) |
Families Citing this family (160)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395506B1 (en) * | 1991-04-18 | 2002-05-28 | Becton, Dickinson And Company | Device for monitoring cells |
| US7657297B2 (en) * | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
| US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6331438B1 (en) | 1999-11-24 | 2001-12-18 | Iowa State University Research Foundation, Inc. | Optical sensors and multisensor arrays containing thin film electroluminescent devices |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| EP1397068A2 (en) | 2001-04-02 | 2004-03-17 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
| US6960466B2 (en) | 2001-05-31 | 2005-11-01 | Instrumentation Laboratory Company | Composite membrane containing a cross-linked enzyme matrix for a biosensor |
| WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
| CA2448902C (en) | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
| CA2448905C (en) | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| AU2002344825A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| ES2352998T3 (en) | 2001-06-12 | 2011-02-24 | Pelikan Technologies Inc. | LANCETA ELECTRIC ACTUATOR. |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
| US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
| US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7002670B2 (en) * | 2002-06-12 | 2006-02-21 | Baxter International Inc. | Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance |
| US7248912B2 (en) * | 2002-10-31 | 2007-07-24 | The Regents Of The University Of California | Tissue implantable sensors for measurement of blood solutes |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| TW200411178A (en) | 2002-12-31 | 2004-07-01 | Veutron Corp | Method for determining the resolution of blood glucose by using rising time curve |
| US6872573B2 (en) | 2003-01-02 | 2005-03-29 | Bayer Corporation | Fluorescent creatinine assay |
| US6999807B2 (en) * | 2003-01-23 | 2006-02-14 | Scimed Life Systems, Inc. | pH measuring balloon |
| TW592667B (en) | 2003-04-04 | 2004-06-21 | Veutron Corp | Method for determining the resolution of blood glucose |
| EP2238892A3 (en) | 2003-05-30 | 2011-02-09 | Pelikan Technologies Inc. | Apparatus for body fluid sampling |
| US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| JP2005151972A (en) * | 2003-07-10 | 2005-06-16 | F Hoffmann La Roche Ag | Nanoparticle for optical sensor |
| CA2473069C (en) * | 2003-07-11 | 2014-03-18 | F. Hoffmann-La Roche Ag | Castable diffusion membrane for enzyme-based sensor application |
| EP1502957B1 (en) * | 2003-07-11 | 2008-08-27 | F. Hoffmann-La Roche Ag | Castable diffusion membrane for enzyme-based sensor application |
| US8282549B2 (en) | 2003-12-09 | 2012-10-09 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
| WO2005011520A2 (en) * | 2003-07-25 | 2005-02-10 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
| US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US20050176136A1 (en) * | 2003-11-19 | 2005-08-11 | Dexcom, Inc. | Afinity domain for analyte sensor |
| US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
| US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
| US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US20080119703A1 (en) | 2006-10-04 | 2008-05-22 | Mark Brister | Analyte sensor |
| US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
| US8285354B2 (en) | 2003-08-01 | 2012-10-09 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US8676287B2 (en) | 2003-08-01 | 2014-03-18 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US7778680B2 (en) | 2003-08-01 | 2010-08-17 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US8233959B2 (en) | 2003-08-22 | 2012-07-31 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US7198855B2 (en) * | 2003-09-12 | 2007-04-03 | Becton, Dickinson And Company | Methods of surface modification of a flexible substrate to enhance cell adhesion |
| US20050059140A1 (en) * | 2003-09-12 | 2005-03-17 | Andrea Liebmann-Vinson | Methods of surface modification to enhance cell adhesion |
| WO2005033659A2 (en) | 2003-09-29 | 2005-04-14 | Pelikan Technologies, Inc. | Method and apparatus for an improved sample capture device |
| WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
| WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
| EP2256493B1 (en) | 2003-12-05 | 2014-02-26 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
| US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
| US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| WO2005057173A2 (en) * | 2003-12-08 | 2005-06-23 | Dexcom, Inc. | Systems and methods for improving electrochemical analyte sensors |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
| WO2009048462A1 (en) | 2007-10-09 | 2009-04-16 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
| US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
| US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
| EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
| US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
| US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
| US8170803B2 (en) | 2004-07-13 | 2012-05-01 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8886272B2 (en) | 2004-07-13 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
| US8097725B2 (en) * | 2004-12-03 | 2012-01-17 | Roche Diagnostics Operations, Inc. | Luminescent indicator dye and optical sensor |
| US20060121547A1 (en) * | 2004-12-03 | 2006-06-08 | Mcintire Mark | Diffusion layer for an enzyme-based sensor application |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| US7860542B2 (en) * | 2005-02-14 | 2010-12-28 | Optiscan Biomedical Corporation | Analyte detection system with reduced sample volume |
| US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
| WO2006110193A2 (en) | 2005-04-08 | 2006-10-19 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
| WO2007120381A2 (en) | 2006-04-14 | 2007-10-25 | Dexcom, Inc. | Analyte sensor |
| US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
| AU2008262018A1 (en) | 2007-06-08 | 2008-12-18 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| AT505337B1 (en) * | 2007-06-14 | 2009-08-15 | Joanneum Res Forschungsgesells | SENSOR FOR THE DETECTION OF GASES |
| WO2009032760A2 (en) | 2007-08-30 | 2009-03-12 | Pepex Biomedical Llc | Electrochmical sensor and method for manufacturing |
| WO2009051901A2 (en) * | 2007-08-30 | 2009-04-23 | Pepex Biomedical, Llc | Electrochemical sensor and method for manufacturing |
| US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
| WO2010056876A2 (en) | 2008-11-14 | 2010-05-20 | Pepex Biomedical, Llc | Manufacturing electrochemical sensor module |
| WO2010056878A2 (en) | 2008-11-14 | 2010-05-20 | Pepex Biomedical, Llc | Electrochemical sensor module |
| US8951377B2 (en) | 2008-11-14 | 2015-02-10 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor module |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| US9446194B2 (en) | 2009-03-27 | 2016-09-20 | Dexcom, Inc. | Methods and systems for promoting glucose management |
| US9378443B2 (en) | 2009-05-14 | 2016-06-28 | Ascensia Diabetes Care Holding Ag | Calibration coded sensors and apparatus, systems and methods for reading same |
| GB2470757B (en) * | 2009-06-04 | 2013-11-06 | Haemaflow Ltd | Non invasive gas analysis |
| US9949672B2 (en) | 2009-12-17 | 2018-04-24 | Ascensia Diabetes Care Holdings Ag | Apparatus, systems and methods for determining and displaying pre-event and post-event analyte concentration levels |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| WO2012064648A1 (en) | 2010-11-12 | 2012-05-18 | Bayer Healthcare Llc | Auto-coded analyte sensors and apparatus, systems, and methods for detecting same |
| DK3575796T3 (en) | 2011-04-15 | 2021-01-18 | Dexcom Inc | ADVANCED ANALYZE SENSOR CALIBRATION AND ERROR DETECTION |
| US9504162B2 (en) | 2011-05-20 | 2016-11-22 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor modules |
| US10561351B2 (en) | 2011-07-26 | 2020-02-18 | Glysens Incorporated | Tissue implantable sensor with hermetically sealed housing |
| JP6059457B2 (en) * | 2011-10-31 | 2017-01-11 | アークレイ株式会社 | Analysis tool and analysis method |
| JP2015512620A (en) | 2012-02-16 | 2015-04-30 | スリーエム イノベイティブ プロパティズ カンパニー | Biological sterilization indicator device and method of use thereof |
| US10561353B2 (en) | 2016-06-01 | 2020-02-18 | Glysens Incorporated | Biocompatible implantable sensor apparatus and methods |
| US10660550B2 (en) | 2015-12-29 | 2020-05-26 | Glysens Incorporated | Implantable sensor apparatus and methods |
| WO2014089058A1 (en) | 2012-12-03 | 2014-06-12 | Pepex Biomedical, Inc. | Sensor module and method of using a sensor module |
| CN107003264B (en) | 2014-06-04 | 2020-02-21 | 普佩克斯生物医药有限公司 | Electrochemical sensor and method of manufacturing an electrochemical sensor using advanced printing techniques |
| US20190000361A1 (en) * | 2015-12-09 | 2019-01-03 | The Texas A&M University System | Implantable biosensors |
| US10638962B2 (en) | 2016-06-29 | 2020-05-05 | Glysens Incorporated | Bio-adaptable implantable sensor apparatus and methods |
| US10638979B2 (en) | 2017-07-10 | 2020-05-05 | Glysens Incorporated | Analyte sensor data evaluation and error reduction apparatus and methods |
| US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
| CN209606445U (en) | 2017-10-24 | 2019-11-08 | 德克斯康公司 | Pre-connection analyte sensor |
| US11278668B2 (en) | 2017-12-22 | 2022-03-22 | Glysens Incorporated | Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods |
| US11255839B2 (en) | 2018-01-04 | 2022-02-22 | Glysens Incorporated | Apparatus and methods for analyte sensor mismatch correction |
| CN111707780A (en) * | 2020-07-03 | 2020-09-25 | 安徽盛世新能源材料科技有限公司 | Chemical detection method for content of antimony trioxide |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT557307A (en) * | 1955-02-23 | 1900-01-01 | ||
| US3992158A (en) * | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
| DE2508637C3 (en) * | 1975-02-28 | 1979-11-22 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Arrangement for the optical measurement of blood gases |
| US4042335A (en) * | 1975-07-23 | 1977-08-16 | Eastman Kodak Company | Integral element for analysis of liquids |
| JPS568549A (en) * | 1979-07-02 | 1981-01-28 | Fuji Photo Film Co Ltd | Multilayer chemical analyzing material |
| US4734375A (en) * | 1980-05-27 | 1988-03-29 | Miles Laboratories, Inc. | Ion specific test method |
| US4476870A (en) * | 1982-03-30 | 1984-10-16 | The United States Of America As Represented By The Department Of Health And Human Services | Fiber optic PO.sbsb.2 probe |
| DE3369801D1 (en) * | 1982-10-06 | 1987-03-19 | Avl Ag | Measurement device for determining the carbon dioxide content of a sample |
| AT379688B (en) * | 1982-11-22 | 1986-02-10 | List Hans | SENSOR ELEMENT FOR DETERMINING THE O2 CONTENT OF A SAMPLE |
| US5030420A (en) * | 1982-12-23 | 1991-07-09 | University Of Virginia Alumni Patents Foundation | Apparatus for oxygen determination |
| JPS59171864A (en) * | 1983-03-18 | 1984-09-28 | Fuji Photo Film Co Ltd | Multi-layered analytical element for quantitative analysis of bilirubin |
| US4649123A (en) * | 1983-05-12 | 1987-03-10 | Miles Laboratories, Inc. | Ion test means having a hydrophilic carrier matrix |
| CA1222438A (en) * | 1983-05-12 | 1987-06-02 | Steven C. Charlton | Unified test means for ion determination |
| JPS60108753A (en) * | 1983-11-18 | 1985-06-14 | Fuji Photo Film Co Ltd | Multilayer chemical analysis element |
| US4670218A (en) * | 1984-02-24 | 1987-06-02 | Miles Laboratories, Inc. | Ion test means having a porous carrier matrix |
| US4752115A (en) * | 1985-02-07 | 1988-06-21 | Spectramed, Inc. | Optical sensor for monitoring the partial pressure of oxygen |
| JPS61245057A (en) * | 1985-04-23 | 1986-10-31 | Fuji Photo Film Co Ltd | Integral type multi-layered analyzing element |
| US4810655A (en) * | 1985-07-03 | 1989-03-07 | Abbott Laboratories | Method for measuring oxygen concentration |
| JPS62503191A (en) * | 1985-07-03 | 1987-12-17 | インタ−ナシヨナル バイオメデイクス，インコ−ポレイテツド | Method and composition for measuring oxygen concentration |
| US5043286A (en) * | 1985-07-03 | 1991-08-27 | Abbott Laboratories | Method and sensor for measuring oxygen concentration |
| US4680268A (en) * | 1985-09-18 | 1987-07-14 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
| US4689309A (en) * | 1985-09-30 | 1987-08-25 | Miles Laboratories, Inc. | Test device, method of manufacturing same and method of determining a component in a sample |
| US4824789B1 (en) * | 1986-10-10 | 1996-08-13 | Minnesota Mining & Mfg | Gas sensor |
| US4919891A (en) * | 1986-04-18 | 1990-04-24 | Minnesota Mining And Manufacturing Company | Sensor with overcoating and process for making same |
| US4895156A (en) * | 1986-07-02 | 1990-01-23 | Schulze John E | Sensor system using fluorometric decay measurements |
| US5190729A (en) * | 1986-09-08 | 1993-03-02 | C. R. Bard, Inc. | Luminescent oxygen sensor based on a lanthanide complex |
| US4861727A (en) * | 1986-09-08 | 1989-08-29 | C. R. Bard, Inc. | Luminescent oxygen sensor based on a lanthanide complex |
| US5075127A (en) * | 1986-10-10 | 1991-12-24 | Minnesota Mining And Manufacturing Company | Sensor with overcoating and process for making same |
| US5352348A (en) * | 1987-04-09 | 1994-10-04 | Nova Biomedical Corporation | Method of using enzyme electrode |
| US4808539A (en) * | 1987-04-15 | 1989-02-28 | Technicon Instruments Corporation | Compounds, reagents and procedures for determining cations |
| IL84422A (en) * | 1987-04-15 | 1993-03-15 | Technicon Instr | Process for the preparation of chromogenic cryptahemispherands |
| US4716363A (en) * | 1987-05-08 | 1987-12-29 | Hewlett-Packard Company | Exponential decay time constant measurement using frequency of offset phase-locked loop: system and method |
| AT389590B (en) * | 1987-05-27 | 1989-12-27 | Avl Verbrennungskraft Messtech | METHOD FOR THE CONTINUOUS, QUANTITATIVE DETERMINATION OF SULFUR DIOXIDE AND ARRANGEMENT FOR IMPLEMENTING THE METHOD |
| AT388248B (en) * | 1987-07-20 | 1989-05-26 | Avl Verbrennungskraft Messtech | COVER LAYER, PREFERABLY FOR SAMPLE-SIDE ATTACHMENT TO OPTICAL ION SENSORS |
| US4974929A (en) * | 1987-09-22 | 1990-12-04 | Baxter International, Inc. | Fiber optical probe connector for physiologic measurement devices |
| US4895798A (en) * | 1987-11-13 | 1990-01-23 | Miles, Inc. | Test devices for determination of occult blood |
| DK163194C (en) * | 1988-12-22 | 1992-06-22 | Radiometer As | METHOD OF PHOTOMETRIC IN VITRO DETERMINING A BLOOD GAS PARAMETER IN A BLOOD TEST |
| US5173432A (en) * | 1987-12-14 | 1992-12-22 | The Dow Chemical Company | Apparatus and method for measuring the concentration or partial pressure of oxygen |
| US5208147A (en) * | 1988-07-21 | 1993-05-04 | Radiometer A/S | Means for measuring a characteristic in a sample fluid |
| US5047350A (en) * | 1989-01-19 | 1991-09-10 | Eastman Kodak Company | Material and method for oxygen sensing |
| DE3923921A1 (en) * | 1989-07-19 | 1991-01-24 | Biotechnolog Forschung Gmbh | OPTICAL BIOSENSOR |
| DE3923950A1 (en) * | 1989-07-19 | 1991-01-31 | Biotechnolog Forschung Gmbh | FIBER OPTICAL SENSOR ARRANGEMENT FOR DETERMINING AN ANALYTIC, IN PARTICULAR OF GLUCOSE |
| US5127405A (en) * | 1990-02-16 | 1992-07-07 | The Boc Group, Inc. | Biomedical fiber optic probe with frequency domain signal processing |
| US5081042A (en) * | 1990-03-20 | 1992-01-14 | Minnesota Mining And Manufacturing Company | Ionic component sensor and method for making and using same |
| US5081041A (en) * | 1990-04-03 | 1992-01-14 | Minnesota Mining And Manufacturing Company | Ionic component sensor and method for making and using same |
| WO1992019957A2 (en) * | 1991-05-03 | 1992-11-12 | University Of Maryland At Baltimore | Method for optically measuring chemical analytes |
| US5281825A (en) * | 1991-09-05 | 1994-01-25 | The University Of Maryland School Of Medicine | Phase fluorometry using a modulated electroluminescent lamp as a light source |
| US6362175B1 (en) * | 1991-09-20 | 2002-03-26 | The Trustees Of The University Of Pennsylvania | Porphyrin compounds for imaging tissue oxygen |
| US5453248A (en) * | 1992-03-09 | 1995-09-26 | Optical Sensors Incorporated | Cross-linked gas permeable membrane of a cured perfluorinated urethane polymer, and optical gas sensors fabricated therewith |
| JP3074361B2 (en) * | 1992-07-15 | 2000-08-07 | セイコーインスツルメンツ株式会社 | Quantitative analyzer |
| US5298144A (en) * | 1992-09-15 | 1994-03-29 | The Yellow Springs Instrument Company, Inc. | Chemically wired fructose dehydrogenase electrodes |
| US5326531A (en) * | 1992-12-11 | 1994-07-05 | Puritan-Bennett Corporation | CO2 sensor using a hydrophilic polyurethane matrix and process for manufacturing |
| US5341805A (en) * | 1993-04-06 | 1994-08-30 | Cedars-Sinai Medical Center | Glucose fluorescence monitor and method |
| US5387329A (en) * | 1993-04-09 | 1995-02-07 | Ciba Corning Diagnostics Corp. | Extended use planar sensors |
| US5387525A (en) * | 1993-09-03 | 1995-02-07 | Ciba Corning Diagnostics Corp. | Method for activation of polyanionic fluorescent dyes in low dielectric media with quaternary onium compounds |
| US5462880A (en) * | 1993-09-13 | 1995-10-31 | Optical Sensors Incorporated | Ratiometric fluorescence method to measure oxygen |
| US5462879A (en) * | 1993-10-14 | 1995-10-31 | Minnesota Mining And Manufacturing Company | Method of sensing with emission quenching sensors |
| US5462858A (en) * | 1993-12-29 | 1995-10-31 | Eastman Kodak Company | Dry multilayer analytical elements for assaying transaminases |
| WO1995026501A1 (en) * | 1994-03-25 | 1995-10-05 | Ciba-Geigy Ag | Optical sensor for the determination of ions |
| US5922612A (en) * | 1994-05-02 | 1999-07-13 | Novartis Corporation | Optical sensor system for determining pH values and ionic strengths |
| US5494562A (en) * | 1994-06-27 | 1996-02-27 | Ciba Corning Diagnostics Corp. | Electrochemical sensors |
| US5605152A (en) * | 1994-07-18 | 1997-02-25 | Minimed Inc. | Optical glucose sensor |
| US5464777A (en) * | 1994-09-26 | 1995-11-07 | Miles Inc. | Dry reagent for creatinine assay |
| US5863460A (en) * | 1996-04-01 | 1999-01-26 | Chiron Diagnostics Corporation | Oxygen sensing membranes and methods of making same |
| AU5079698A (en) * | 1996-10-08 | 1998-05-05 | Photonics Biosystems | Microbiological assessment method and device utilizing oxygen gradient sensing |
-
1998
- 1998-08-21 US US09/137,616 patent/US6107083A/en not_active Expired - Lifetime
-
1999
- 1999-08-19 CA CA002340983A patent/CA2340983A1/en not_active Abandoned
- 1999-08-19 EP EP99936915A patent/EP1112374A1/en not_active Withdrawn
- 1999-08-19 JP JP2000566457A patent/JP2002523733A/en not_active Withdrawn
- 1999-08-19 AU AU51883/99A patent/AU5188399A/en not_active Abandoned
- 1999-08-19 WO PCT/IB1999/001451 patent/WO2000011205A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1112374A1 (en) | 2001-07-04 |
| JP2002523733A (en) | 2002-07-30 |
| AU5188399A (en) | 2000-03-14 |
| WO2000011205A1 (en) | 2000-03-02 |
| US6107083A (en) | 2000-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6107083A (en) | Optical oxidative enzyme-based sensors | |
| Wolfbeis et al. | Reversible optical sensor membrane for hydrogen peroxide using an immobilized fluorescent probe, and its application to a glucose biosensor | |
| US6254831B1 (en) | Optical sensors with reflective materials | |
| Preininger et al. | Optical fiber sensor for biological oxygen demand | |
| JP4272347B2 (en) | Method and apparatus for normalizing fluorescence intensity signals | |
| Tsai et al. | Simultaneous determination of pH, urea, acetylcholine and heavy metals using array-based enzymatic optical biosensor | |
| Papkovsky | Luminescent porphyrins as probes for optical (bio) sensors | |
| Preininger et al. | Disposable cuvette test with integrated sensor layer for enzymatic determination of heavy metals | |
| KR101164048B1 (en) | Method and reagent system having a non-regenerative enzyme-coenzyme complex | |
| EP1000171B1 (en) | Fluorescent polymeric sensor for the detection of urea | |
| US20060121547A1 (en) | Diffusion layer for an enzyme-based sensor application | |
| Abel et al. | Fast responsive, optical trace level ammonia sensor for environmental monitoring | |
| Neubauer et al. | Fibre-optic glucose biosensor using enzyme membranes with 2-D crystalline structure | |
| US20040171094A1 (en) | Oxygen sensors disposed on a microtiter plate | |
| JP2004517321A (en) | Sensor for optical emission measurement of analytes | |
| Koncki et al. | Optical chemical sensing based on thin films of Prussian Blue | |
| Turel et al. | Direct UV-LED lifetime pH sensor based on a semi-permeable sol–gel membrane immobilized luminescent Eu3+ chelate complex | |
| Posch et al. | Optical sensor for hydrogen peroxide | |
| US6241948B1 (en) | Sensing device with sol-gel derived film on the light source | |
| Guo et al. | A novel sensor based on the porous plastic probe for determination of dissolved oxygen in seawater | |
| EP0916091B1 (en) | Light-sensitive compositions for oxygen optrodes | |
| EP1496126B1 (en) | Nanoparticles for optical sensors | |
| de Marcos et al. | Characterization of a urea optical sensor based on polypyrrole | |
| Huber et al. | Serum chloride optical sensors based on dynamic quenching of the fluorescence of photo-immobilized lucigenin | |
| US7427491B2 (en) | Nanoparticles for optical sensors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |